Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAI vs Placebo in Advanced NSCLC
NCT00003869Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1999
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carboxyamidotriazole in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Apr 1999; status: completed.
02
Drugs
carboxyamidotriazole
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003869.